title: The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.
authors.affiliation: Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel. Electronic address: Shouval@hadassah.org.il.
authors.forename: Daniel
authors.initials: D
authors.lastname: Shouval
mesh_terms: D065290:Acute-On-Chronic Liver Failure / Q000188:drug therapy*; D058625:End Stage Liver Disease / Q000188:drug therapy*; D005260:Female; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008297:Male
chemical_list: D019259:Lamivudine; C413685:entecavir; D006147:Guanine